Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-26-014692
Filing Date
2026-04-01
Accepted
2026-04-01 16:50:59
Documents
9

Document Format Files

Seq Description Document Type Size
1 424B3 form424b3.htm 424B3 2176578
2 GRAPHIC form424b3_001.jpg GRAPHIC 3555
3 GRAPHIC form10-k_001.jpg GRAPHIC 32378
4 GRAPHIC form10-k_002.jpg GRAPHIC 31387
5 GRAPHIC ex10-69_001.jpg GRAPHIC 251513
6 GRAPHIC ex10-69_002.jpg GRAPHIC 616554
7 GRAPHIC ex10-69_003.jpg GRAPHIC 232249
8 GRAPHIC ex10-69_004.jpg GRAPHIC 361968
9 GRAPHIC ex10-69_005.jpg GRAPHIC 520636
  Complete submission text file 0001493152-26-014692.txt   5002147
Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Filer) CIK: 0001962011 (see all company filings)

EIN.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-284569 | Film No.: 26829123
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)